Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-16-093297
Filing Date
2016-01-22
Accepted
2016-01-22 19:08:50
Documents
2
Period of Report
2016-01-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 14161
2 POA DOCUMENT poa.txt EX-24.3_627692 4217
  Complete submission text file 0001209191-16-093297.txt   19956
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 500 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 500 SAN DIEGO CA 92130 8585520866
Mast Therapeutics, Inc. (Issuer) CIK: 0001160308 (see all company filings)

EIN.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3611 VALLEY CENTRE DRIVE, SUITE 500 SAN DIEGO CA 92130
Business Address
Hood Shana (Reporting) CIK: 0001663796 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-32157 | Film No.: 161357239